Related Experiment Video

Updated: Jul 16, 2026

An Orthotopic Murine Model of Human Prostate Cancer Metastasis
06:48

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Published on: September 18, 2013

Stabilizing androgen receptor in mitosis inhibits prostate cancer proliferation

Donald J Vander Griend1, Ivan V Litvinov, John T Isaacs

  • 1Chemical Therapeutics Program, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Cell Cycle (Georgetown, Tex.)
|March 28, 2007
PubMed

Insights

Androgen receptor (AR) degradation during mitosis is crucial for prostate cancer cell replication. Incomplete AR degradation halts cell proliferation, suggesting AR stabilization as a novel therapeutic strategy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • The androgen receptor (AR) is a key driver of prostate cancer progression.
  • AR activity is targeted by androgen ablation therapies for advanced prostate cancer.
  • AR gain-of-function mutations promote prostate cancer cell survival and proliferation.

Purpose of the Study:

  • To investigate the role of AR degradation during mitosis in prostate cancer.
  • To determine the consequences of impaired AR degradation on cell proliferation.
  • To explore AR stabilization as a potential therapeutic strategy.

Main Methods:

  • Studied AR expression and degradation dynamics in prostate cancer cells.
  • Utilized techniques to induce acute enhanced AR expression during mitosis.
  • Assessed the impact of altered AR degradation on DNA replication licensing and cell proliferation.

Main Results:

  • AR functions as a licensing factor for DNA replication in prostate cancer cells.
  • Complete AR degradation during mitosis is essential for subsequent cell cycle relicensing.
  • Acute enhancement of AR expression leads to incomplete mitotic degradation, inhibiting proliferation.

Conclusions:

  • Incomplete mitotic AR degradation is a critical mechanism that limits prostate cancer cell proliferation.
  • These findings offer a unifying explanation for previously unresolved observations in prostate cancer.
  • Stabilization of AR presents a novel therapeutic rationale for prostate cancer treatment.

More Related Videos

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR (qPCR)08:30

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR (qPCR)

Published on: May 16, 2012

Prostate Organoid Cultures as Tools to Translate Genotypes and Mutational Profiles to Pharmacological Responses08:36

Prostate Organoid Cultures as Tools to Translate Genotypes and Mutational Profiles to Pharmacological Responses

Published on: October 24, 2019

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...